Plain-English translation of NCT06515587 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing whether two blood tests — Lewis antigen detection and CA19-9 testing — can help doctors better predict how pancreatic cancer will progress in individual patients. Researchers will collect blood samples from people with confirmed pancreatic cancer and from people without pancreatic cancer to understand how these tests work and what they can tell us about prognosis.
Doctors need better ways to predict how pancreatic cancer will develop in each patient so they can plan treatment and help patients understand what to expect. This study explores whether these blood tests can provide that information more accurately.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood drawn (about 2–3 milliliters) for Lewis antigen testing and CA19-9 testing. Researchers will track your survival and health outcomes over time to see how the blood test results relate to how your cancer progresses. The study is being conducted at multiple hospitals, and your participation involves allowing researchers to follow your medical care and outcomes.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China